アジア太平洋のプロテオミクス市場：オファリング別、用途別、国別 - 分析と予測（2024年～2034年）

アジア太平洋のプロテオミクスの市場規模は、2024年の69億5,000万米ドルから2034年には257億8,000万米ドルに達し、予測期間の2024年～2034年のCAGRは14.01%になると予測されています。

アジア太平洋のプロテオミクス産業は、高精度のタンパク質分析と質量分析を提供する次世代シーケンス技術の開発により急速に拡大しています。個別化ヘルスケアが重視されるようになり、新たなバイオマーカーの発見や疾患プロファイリングツールの改善が試みられていることも、この動向の一因となっています。

官民パートナーシップの拡大や、病院、バイオテクノロジー会社、学術機関の協力により、新しいプロテオミクスの応用はより迅速に開発されつつあり、またアジア太平洋各国の政府は国家的な資金調達プログラムを通じて研究開発とイノベーションを促進しています。さらに、同地域の高齢者人口の増加や慢性疾患の有病率の増加により、より優れた診断機器や早期発見技術が急務となっています。

アジア太平洋はライフサイエンスへの投資を続け、臨床研究インフラを強化しているため、プロテオミクスは地域全体で精密医療とヘルスケアイノベーションを促進する重要な柱として浮上しています。

プロテオミクスは、アジア太平洋のライフサイエンスバイオテクノロジー分野において、急速に市場開拓が進んでいる有望市場です。質量分析、次世代シーケンシング（NGS）、バイオインフォマティクスなどの分析技術の開発により、プロテオミクスソリューションは、この地域全体の研究、診断、医薬品開発アプリケーションでますます使用されるようになっています。臨床研究およびトランスレーショナル・リサーチにおいて、より詳細なタンパク質レベルの知見が必要とされる傾向は、ヘルスケア支出の増加、慢性疾患の発生率、個別化治療の傾向によって加速しています。

中国、インド、日本、韓国、シンガポールの各政府は、国家的研究開発イニシアティブ、インフラ整備、財政プログラムを通じてプロテオミクスを推進しています。プロテオミクスの技術やプラットフォームにおけるイノベーションは、バイオテクノロジー会社、学術機関、ヘルスケアプロバイダー間の官民パートナーシップによっても加速されています。さらに、タンパク質データ処理におけるAIと機械学習の統合が進むことで、精度、スピード、スケーラビリティが向上しています。

こうした開発にもかかわらず、法外な技術コスト、有能な人材の不足、低開発国における最先端研究施設へのアクセス制限などの問題は依然として存在します。しかし、精密ヘルスケアへの関心と資金が高まり続ける中、アジア太平洋プロテオミクス市場は着実に成長し、この地域全体の診断・治療アプローチを変える上で重要な役割を果たすと期待されています。

市場セグメンテーション

セグメンテーション1：製品別

• 製品
• サービス

セグメンテーション2：用途別

• 創薬
• 臨床診断
• その他

セグメンテーション3：地域別

• アジア太平洋
  • 中国
  • 日本
  • インド
  • 韓国
  • オーストラリア
  • その他

アジア太平洋プロテオミクス市場動向と促進要因・課題

動向

• 質量分析や次世代シーケンシングのようなハイスループット技術の採用増加
• 個別化医療と精密ヘルスケアへの注目の高まり
• 疾病診断、医薬品開発、バイオマーカー探索におけるプロテオミクス応用の開発拡大
• 産学連携や官民研究パートナーシップの拡大
• プロテオミクスデータ解析におけるAIとバイオインフォマティクスの統合

促進要因

• 国の研究開発プログラムやヘルスケア近代化イニシアティブを通じた政府の支援
• バイオテクノロジー企業や製薬企業別プロテオミクス研究への投資の拡大
• 慢性疾患の増加と高齢化が早期発見の需要を促進
• 新興アジア太平洋諸国におけるヘルスケア支出の増加とインフラの改善
• 同地域における臨床試験およびトランスレーショナルリサーチの急増

課題

• プロテオミクス機器とデータ解析プラットフォームの高コスト
• 中低所得国における先端技術へのアクセス制限
• 熟練した専門家やバイオインフォマティクスの専門家の不足
• 複雑なデータ解釈と標準化の問題
• 患者データの使用やバイオマーカーの検証に関する規制や倫理上の問題

製品/イノベーション戦略：アジア太平洋のプロテオミクス市場は、製品、用途、国などのさまざまなカテゴリーに基づいて広範にセグメント化されています。これにより読者は、どのセグメントが最大のシェアを占め、どのセグメントが今後数年間で成長する可能性が高いかについて、明確な概観を得ることができます。

競合戦略：アジア太平洋のプロテオミクス市場には、製品・サービスポートフォリオを持つ数多くの既存企業が存在します。本調査で分析・プロファイルしたアジア太平洋地域のプロテオミクス市場における主要企業には、プロテオミクス製品やサービスを提供する既存企業が含まれます。

当レポートでは、アジア太平洋のプロテオミクス市場について調査し、市場の概要とともに、オファリング別、用途別、国別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

エグゼクティブサマリー

第1章 市場

• 市場見通し
• 主な調査結果
• アジア太平洋のプロテオミクス市場シナリオ
• 業界展望
• 動向：現状と将来への影響評価
• 特許分析
• 規制の枠組み
• 製品ベンチマーク
• 市場力学の概要

第2章 プロテオミクス市場（地域別）、100万米ドル、2022年～2034年

• 地域サマリー
• アジア太平洋
  • 地域概要
  • 市場成長促進要因
  • 市場成長抑制要因
  • アジア太平洋のプロテオミクス市場（用途別）
  • アジア太平洋のプロテオミクス市場（オファリング別）
  • 中国
  • インド
  • オーストラリア
  • 日本
  • 韓国
  • その他

第3章 市場-競合ベンチマーキングと企業プロファイル

• プロテオミクス市場：競合情勢
  • 企業戦略2022年1月～2024年12月
• 企業プロファイル
  • Takara Bio Inc.

第4章 調査手法

List of Figures

• Figure 1: Asia-Pacific Proteomics Market (by Application), $Billion, 2022, 2027, and 2034
• Figure 2: Asia-Pacific Proteomics Market (by Product), $Billion, 2022, 2027, and 2034
• Figure 3: Key Events to Keep Track of within the Proteomics Market
• Figure 4: Asia-Pacific Proteomics Market Size, $Billion, 2022-2034
• Figure 5: Proteomics Literature Published (January 2015 to December 2024)
• Figure 6: Asia-Pacific Proteomics Market Size and Growth Potential (Realistic Scenario), $Billion, 2022-2034
• Figure 7: Asia-Pacific Proteomics Market Size and Growth Potential (Optimistic Scenario), $Billion, 2022 to 2034
• Figure 8: Asia-Pacific Proteomics Market Size and Growth Potential (Pessimistic Scenario), $Billion, 2022 to 2034
• Figure 9: Supply Chain and Risks within the Supply Chain
• Figure 10: Key Features of End-to-End Proteomics Workflow
• Figure 11: Proteomics Market, Patent Analysis (by Country), January 2021-December 2024
• Figure 12: Proteomics Market, Patent Analysis (by Year), January 2021-December 2024
• Figure 13: Proteomics Market, Product Benchmarking (by Product)
• Figure 14: Impact Analysis of Market Navigating Factors, 2024-2034
• Figure 15: Timeline on the Personalized Medicine Journey of Protein
• Figure 16: Difficulties Faced in Top-Down Proteomics
• Figure 17: Future Outlook of Nanoproteomics
• Figure 18: Asia-Pacific Proteomics Market, $Billion, 2022-2034
• Figure 19: Proteomics Literature Published in China (January 2015 to December 2024)
• Figure 20: China Proteomics Market, $Billion, 2022-2034
• Figure 21: Proteomics Literature Published in India (January 2015 to December 2024)
• Figure 22: India Proteomics Market, $Billion, 2022-2034
• Figure 23: Proteomics Literature Published in Australia (January 2015 to December 2024)
• Figure 24: Australia Proteomics Market, $Billion, 2022-2034
• Figure 25: Proteomics Literature Published in Japan (January 2015 to December 2024)
• Figure 26: Japan Proteomics Market, $Billion, 2022-2034
• Figure 27: Proteomics Literature Published in South Korea (January 2015 to December 2024)
• Figure 28: South Korea Proteomics Market, $Billion, 2022-2034
• Figure 29: Rest-of-Asia-Pacific Proteomics Market, $Billion, 2022-2034
• Figure 30: Corporate Strategies, January 2022-December 2024
• Figure 31: Data Triangulation
• Figure 32: Top-Down and Bottom-Up Approach
• Figure 33: Assumptions and Limitations

List of Tables

• Table 1: Market Snapshot
• Table 2: Opportunities across Regions
• Table 3: The Diversified Exposure of Proteomics
• Table 4: Comparative Analysis of Proteomics: Advantages and Disadvantages Over Other Omics Approaches
• Table 5: Introduction to Proteomics Techniques: Principles, Advantages, and Limitations
• Table 6: Comparison of Existing and Emerging Paradigms in Proteomics Technologies
• Table 7: Proteomics Market Trend Analysis
• Table 8: Some of the Partnerships and Collaborations in the Proteomics Market
• Table 9: List of Molecular Targets Identified with Proteomics
• Table 10: Cancer Cases Expected Between 2020 and 2040
• Table 11: Proteomics Market, Regulatory Approvals, and New Offerings
• Table 12: Cancer Biomarkers Discovered by Proteomics and its Applications in Personalized Medicine
• Table 13: Proteomics Market (by Region), $Billion, 2022-2034
• Table 14: Asia-Pacific Proteomics Market (by Application), $Billion, 2022-2034
• Table 15: Asia-Pacific Proteomics Market (by Offering), $Billion, 2022-2034
• Table 16: Asia-Pacific Proteomics Market (by Product), $Billion, 2022-2034
• Table 17: China Proteomics Market (by Application), $Billion, 2022-2034
• Table 18: China Proteomics Market (by Offering), $Billion, 2022-2034
• Table 19: China Proteomics Market (by Product), $Billion, 2022-2034
• Table 20: India Proteomics Market (by Application), $Billion, 2022-2034
• Table 21: India Proteomics Market (by Offering), $Billion, 2022-2034
• Table 22: India Proteomics Market (by Product), $Billion, 2022-2034
• Table 23: Australia Proteomics Market (by Application), $Billion, 2022-2034
• Table 24: Australia Proteomics Market (by Offering), $Billion, 2022-2034
• Table 25: Australia Proteomics Market (by Product), $Billion, 2022-2034
• Table 26: Japan Proteomics Market (by Application), $Billion, 2022-2034
• Table 27: Japan Proteomics Market (by Offering), $Billion, 2022-2034
• Table 28: Japan Proteomics Market (by Product), $Billion, 2022-2034
• Table 29: South Korea Proteomics Market (by Application), $Billion, 2022-2034
• Table 30: South Korea Proteomics Market (by Offering), $Billion, 2022-2034
• Table 31: South Korea Proteomics Market (by Product), $Billion, 2022-2034
• Table 32: Rest-of-Asia-Pacific Proteomics Market (by Application), $Billion, 2022-2034
• Table 33: Rest-of-Asia-Pacific Proteomics Market (by Offering), $Billion, 2022-2034
• Table 34: Rest-of-Asia-Pacific Proteomics Market (by Product), $Billion, 2022-2034

Introduction to Asia-Pacific Proteomics Market

The Asia-Pacific proteomics market is projected to reach $25.78 billion by 2034 from $6.95 billion in 2024, growing at a CAGR of 14.01% during the forecast period 2024-2034. The Asia-Pacific (APAC) proteomics industry is expanding rapidly due to developments in next-generation sequencing technologies that provide high-precision protein analysis and mass spectrometry. The growing emphasis on individualised healthcare, together with increased attempts to find new biomarkers and improve disease profiling tools, is another factor contributing to this trend.

New proteomic applications are being developed more quickly thanks to expanding public-private partnerships and cooperation between hospitals, biotech companies, and academic institutions, while governments around APAC are promoting research and innovation through national financing programs. Furthermore, there is an urgent need for better diagnostic instruments and early detection techniques due to the region's growing senior population and the increase in the prevalence of chronic illnesses.

Proteomics is emerging as a key pillar in promoting precision medicine and healthcare innovation across the region as APAC keeps investing in life sciences and fortifying its clinical research infrastructure.

Market Introduction

Proteomics is a fast developing, high-potential market in the life sciences and biotechnology sector in Asia-Pacific (APAC). Proteomic solutions are increasingly being used in research, diagnostics, and drug development applications throughout the region, driven by developments in analytical technologies including mass spectrometry, next-generation sequencing (NGS), and bioinformatics. The need for more in-depth protein-level insights in clinical and translational research is being fuelled by rising healthcare expenditures, the incidence of chronic diseases, and the trend towards personalised therapy.

Governments in China, India, Japan, South Korea, and Singapore promote proteomics through national R&D initiatives, infrastructure development, and financial programs. Innovation in proteomics techniques and platforms is also being accelerated by public-private partnerships among biotech companies, academic institutions, and healthcare providers. Furthermore, accuracy, speed, and scalability are being improved by the increasing integration of AI and machine learning in protein data processing.

Notwithstanding these developments, issues including exorbitant technological costs, a shortage of qualified personnel, and restricted access to cutting-edge research facilities in underdeveloped countries continue to exist. But as interest in and funding for precision healthcare continue to rise, the APAC proteomics market is expected to grow steadily and play a significant part in changing diagnostic and treatment approaches throughout the area.

Market Segmentation:

Segmentation 1: by Offering

• Product
• Service

Segmentation 2: by Application

• Drug Discovery
• Clinical Diagnostics
• Others

Segmentation 3: by Region

• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest-of-Asia-Pacific

APAC Proteomics Market Trends, Drivers and Challenges

Trends

• Increasing adoption of high-throughput technologies like mass spectrometry and next-generation sequencing
• Rising focus on personalized medicine and precision healthcare
• Expansion of proteomic applications in disease diagnostics, drug development, and biomarker discovery
• Growth in academic-industry collaborations and public-private research partnerships
• Integration of AI and bioinformatics in proteomic data analysis

Drivers

• Government support through national R&D programs and healthcare modernization initiatives
• Growing investment by biotech and pharmaceutical companies in proteomic research
• Rising prevalence of chronic diseases and aging population driving demand for early detection
• Increased healthcare spending and improved infrastructure across emerging APAC economies
• Surge in clinical trials and translational research efforts in the region

Challenges

• High cost of proteomics instruments and data analysis platforms
• Limited access to advanced technologies in low- and middle-income countries
• Shortage of skilled professionals and bioinformatics expertise
• Complex data interpretation and standardization issues
• Regulatory and ethical concerns around patient data use and biomarker validation

How can this report add value to an organization?

Product/Innovation Strategy: The Asia-Pacific proteomics market has been extensively segmented based on various categories, such as offering, application, and country. This can help readers get a clear overview of which segments account for the largest share and which ones are well-positioned to grow in the coming years.

Competitive Strategy: The Asia-Pacific proteomics market has numerous established players with product and service portfolios. Key players in the Asia-Pacific proteomics market analyzed and profiled in the study involve established players offering proteomics products and services.

Table of Contents

Executive Summary

Scope and Definition

1 Market

• 1.1 Market Outlook
  • 1.1.1 Comparative Advantages and Disadvantages of Proteomics Over Other Omics
  • 1.1.2 Proteomics Techniques by Introduction with Principles and Advantages/Limitations
• 1.2 Key Findings
• 1.3 Asia-Pacific Proteomics Market Scenario
  • 1.3.1 Realistic Scenario
  • 1.3.2 Optimistic Scenario
  • 1.3.3 Pessimistic Scenario
• 1.4 Industry Outlook
  • 1.4.1 Supply Chain Overview
• 1.5 Trends: Current and Future Impact Assessment
  • 1.5.1 Increasing Automation for End-to-End Proteomics Workflow
  • 1.5.2 Significant Number of Collaborations among Market Players
  • 1.5.3 Growing Proteomics Research to Identify Disease Biomarkers
• 1.6 Patent Analysis
  • 1.6.1 Patent Filing Trend (by Country, Year)
• 1.7 Regulatory Framework
  • 1.7.1 Japan
    • 1.7.1.1 Regulatory Requirements for Proteomics Products Intended as Medical Devices
    • 1.7.1.2 Regulatory Requirements for Clinical Proteomics Labs in Japan
  • 1.7.2 China
    • 1.7.2.1 Regulatory Requirements for Proteomics Products Intended as Medical Devices
• 1.8 Product Benchmarking
• 1.9 Market Dynamics Overview
  • 1.9.1 Market Drivers
    • 1.9.1.1 Increasing Prevalence of Chronic Diseases
    • 1.9.1.2 Increasing Technological Advancements
    • 1.9.1.3 Advancements in Personalized Medicine and Drug Discovery
  • 1.9.2 Market Restraints
    • 1.9.2.1 Shortage of Skilled Professionals
    • 1.9.2.2 Complexity in Analyzing Data of Proteomics Research
  • 1.9.3 Market Opportunities
    • 1.9.3.1 Progress in Nanoproteomics Platforms to Enhance and Thoroughly Analyze Natural Protein Complexes

2 Proteomics Market (by Region), $Million, 2022-2034

• 2.1 Regional Summary
• 2.2 Asia-Pacific
  • 2.2.1 Regional Overview
  • 2.2.2 Driving Factors for Market Growth
  • 2.2.3 Factors Challenging the Market
  • 2.2.4 Asia-Pacific Proteomics Market, by Application
  • 2.2.5 Asia-Pacific Proteomics Market, by Offering
    • 2.2.5.1 Asia-Pacific Proteomics Market, by Product
  • 2.2.6 China
    • 2.2.6.1 China Proteomics Market, by Application
    • 2.2.6.2 China Proteomics Market, by Offering
      • 2.2.6.2.1 China Proteomics Market, by Product
  • 2.2.7 India
    • 2.2.7.1 India Proteomics Market, by Application
    • 2.2.7.2 India Proteomics Market, by Offering
      • 2.2.7.2.1 India Proteomics Market, by Product
  • 2.2.8 Australia
    • 2.2.8.1 Australia Proteomics Market, by Application
    • 2.2.8.2 Australia Proteomics Market, by Offering
      • 2.2.8.2.1 Australia Proteomics Market, by Product
  • 2.2.9 Japan
    • 2.2.9.1 Japan Proteomics Market, by Application
    • 2.2.9.2 Japan Proteomics Market, by Offering
      • 2.2.9.2.1 Japan Proteomics Market, by Product
  • 2.2.10 South Korea
    • 2.2.10.1 South Korea Proteomics Market, by Application
    • 2.2.10.2 South Korea Proteomics Market, by Offering
      • 2.2.10.2.1 South Korea Proteomics Market, by Product
  • 2.2.11 Rest-of-Asia-Pacific
    • 2.2.11.1 Rest-of-Asia-Pacific Proteomics Market, by Application
    • 2.2.11.2 Rest-of-Asia-Pacific Proteomics Market, by Offering
      • 2.2.11.2.1 Rest-of-Asia-Pacific Proteomics Market, by Product

3 Markets - Competitive Benchmarking & Company Profiles

• 3.1 Proteomics Market: Competitive Landscape
  • 3.1.1 Corporate Strategies, January 2022-December 2024
• 3.2 Company Profiles
  • 3.2.1 Takara Bio Inc.
    • 3.2.1.1 Overview
    • 3.2.1.2 Top Products/ Services
    • 3.2.1.3 Top Competitors
    • 3.2.1.4 Target Customers
    • 3.2.1.5 Key Personnel
    • 3.2.1.6 Analyst View

4 Research Methodology

• 4.1 Data Sources
  • 4.1.1 Primary Data Sources
  • 4.1.2 Secondary Data Sources
  • 4.1.3 Data Triangulation
• 4.2 Market Estimation and Forecast